LA JOLLA, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Leios Therapeutics, a clinical-stage biotechnology company focused on innovative aesthetic therapies, today announced the execution of a licensing ...
10XB-101 Being Developed for Focal Fat Reduction and Body Contouring LA JOLLA, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Leios Therapeutics, a clinical-stage biotechnology company focused on ...
Palo Alto’s Architectural Review Board wants to ensure the city’s first housing development east of Highway 101 is suitable for children, the elderly, the disabled and first-time homebuyers. Michael ...
Jacob Sipe has been chosen to serve as the new Community Development Director for the city of Columbus. According to the announcement from the city, previously Sipe was executive director of the ...
MADISON, Wis.--(BUSINESS WIRE)--Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies, and the Wisconsin Alumni Research Foundation (WARF), the patenting and ...
Hosted on MSN
Psychic Medium Ability 101
Matt Fraser provides an introductory explanation of the fundamental aspects of psychic mediumship abilities. Here is how California Gov. Gavin Newsom plans to address a $12 billion budget shortfall ...
Getting a psychic reading every once in a while can provide valuable insights and guidance, helping you navigate life’s challenges with more clarity. However, finding honest psychics online who offer ...
Mindimmune Therapeutics Inc. has been awarded a grant by Rhode Island Life Science Hub to accelerate preclinical development work on MITI-101 for the treatment of mild to moderate Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results